ADKN, CO. is a student group in the Strategic Marketing class at Saint Joseph's University. By leveraging a new therapeutic category, Qsymia could ultimately become a market leader.
Approved in July 2012, patent expires in June 2020Retail price of $160 for a 30-day recommended dose, approved by Aetna in November 2012 for overweight or obese patients in its formulary
Approved in July 2012, patent expires in June 2020Retail price of $160 for a 30-day recommended dose, approved by Aetna in November 2012 for overweight or obese patients in its formulary
Approved in July 2012, patent expires in June 2020Retail price of $160 for a 30-day recommended dose, approved by Aetna in November 2012 for overweight or obese patients in its formulary
Approved in July 2012, patent expires in June 2020Retail price of $160 for a 30-day recommended dose, approved by Aetna in November 2012 for overweight or obese patients in its formulary